Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1900 to 1949 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1900\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
seven in absentia homolog 2. [source:refseq;acc:nm\_005067]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5399.47\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5737.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06266\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1901\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
inorganic pyrophosphatase (ec 3.6.1.1) (pyrophosphate phospho- hydrolase) (ppase). [source:swissprot;acc:q15181]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5204.25\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5530.11\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06261\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1902\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
inorganic pyrophosphatase 2 isoform 1. [source:refseq;acc:nm\_176869]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1903\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
aryl-hydrocarbon interacting protein-like 1. [source:swissprot;acc:q9nzn9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1904\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ah receptor-interacting protein (aip) (immunophilin homolog ara9) (hbv-x associated protein 2). [source:swissprot;acc:o00170]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1905\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
son of sevenless protein homolog 2 (sos-2). [source:swissprot;acc:q07890]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7497.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7967.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06257\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1906\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l18. [source:refseq;acc:nm\_014161]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5396.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5733.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06251\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1907\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatitis c virus core-binding protein 6; cervical cancer oncogene 3. [source:refseq;acc:nm\_023934]\vspace{3pt}}&\multirow{11}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6858.84\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7287.27\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06246\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1908\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dc11 protein. [source:refseq;acc:nm\_020186]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1909\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
amyloid beta precursor protein-binding protein 1; amyloid protein-binding protein 1. [source:refseq;acc:nm\_003905]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1910\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
5-aminolevulinic acid synthase, erythroid-specific, mitochondrial precursor (ec 2.3.1.37) (delta-aminolevulinate synthase) (delta-ala synthetase) (alas-e). [source:swissprot;acc:p22557]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1911\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-activating enzyme e1c (uba3 homolog, yeast); ubiquitin-activating enzyme e1c (homologous to yeast uba3). [source:refseq;acc:nm\_003968]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1912\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-activating enzyme e1 (a1s9 protein). [source:swissprot;acc:p22314]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1913\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcium-binding mitochondrial carrier protein aralar1 (solute carrier family 25, member 12). [source:swissprot;acc:o75746]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1914\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma antigen recognized by t cells 2. [source:refseq;acc:nm\_018194]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1915\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
5-aminolevulinic acid synthase, nonspecific, mitochondrial precursor (ec 2.3.1.37) (delta-aminolevulinate synthase) (delta-ala synthetase) (alas-h). [source:swissprot;acc:p13196]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1916\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcium-binding mitochondrial carrier protein aralar2 (solute carrier family 25, member 13) (citrin). [source:swissprot;acc:q9ujs0]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1917\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
acyl carrier protein, mitochondrial precursor (acp) (nadh-ubiquinone oxidoreductase 9.6 kda subunit) (ci-sdap). [source:swissprot;acc:o14561]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1918\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
seven in absentia homolog 1. [source:refseq;acc:nm\_003031]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5394.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5730.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06238\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1919\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hydroxyindole o-methyltransferase (ec 2.1.1.4) (hiomt) (acetylserotonin o-methyltransferase) (asmt). [source:swissprot;acc:p46597]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5444.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5783.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06233\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1920\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
basic proline-rich peptide p-e (ib-9). [source:swissprot;acc:p02811]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6262.66\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6652.85\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0623\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1921\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
salivary proline-rich protein po (allele k) [contains: peptide p-d] (fragment). [source:swissprot;acc:p10162]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1922\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hsp90 co-chaperone cdc37 (hsp90 chaperone protein kinase-targeting subunit) (p50cdc37). [source:swissprot;acc:q16543]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5567.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5914.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06226\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1923\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
brain protein 16. [source:refseq;acc:nm\_016458]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5774.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6133.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06217\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1924\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcriptional adaptor 3-like isoform a. [source:refseq;acc:nm\_006354]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
7260.23\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7711.3\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06213\vspace{3pt}}}\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1925\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bromodomain containing 7; bromodomain protein; bromodomain-containing 7. [source:refseq;acc:nm\_013263]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7711.29\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1926\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
frg1 protein (fshd region gene 1 protein). [source:swissprot;acc:q14331]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7711.3\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1927\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcriptional adapter 2-like (ada2-like protein) (kl04p). [source:swissprot;acc:o75478]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1928\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
son of sevenless protein homolog 1 (sos-1). [source:swissprot;acc:q07889]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7514.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7980.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06193\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1929\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pxr2b protein. [source:refseq;acc:nm\_016559]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6996.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7429.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06184\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1930\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
p28 ing5. [source:refseq;acc:nm\_032329]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5784.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6141.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06179\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1931\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ring finger protein 25 (ec 6.3.2.-). [source:swissprot;acc:q96bh1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9946.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9367.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06176\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1932\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocyte growth factor-regulated tyrosine kinase substrate; human growth factor-regulated tyrosine kinase substrate. [source:refseq;acc:nm\_004712]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
10300\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
9701.33\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06171\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1933\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
conserved oligomeric golgi complex component 7. [source:swissprot;acc:p83436]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1934\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transducin beta-like 2 protein (ws beta-transducin repeats protein) (ws-betatrp) (williams-beuren syndrome chromosome region 13 protein). [source:swissprot;acc:q9y4p3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5949.31\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6313.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06115\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1935\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine palmitoyltransferase 1 (ec 2.3.1.50) (long chain base biosynthesis protein 1) (lcb 1) (serine-palmitoyl-coa transferase 1) (spt 1) (spt1). [source:swissprot;acc:o15269]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6167.29\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6544.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0611\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1936\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
williams-beuren syndrome critical region protein 20 copy b. [source:refseq;acc:nm\_145645]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5171.45\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5486.96\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06101\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1937\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
williams beuren syndrome critical region 20a isoform 2; nol1/nop2/sun gene family member; williams-beuren syndrome critical region protein 20 copy a; williams beuren syndrome chromosome region 20. [source:refseq;acc:nm\_018044]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1938\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
williams beuren syndrome chromosome region 20c isoform 1. [source:refseq;acc:nm\_032158]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1939\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
brca1-associated ring domain protein 1 (bard-1). [source:swissprot;acc:q99728]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5669.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6015.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.061\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1940\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
m-phase inducer phosphatase 3 (ec 3.1.3.48) (dual specificity phosphatase cdc25c). [source:swissprot;acc:p30307]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4450.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4721.37\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06094\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1941\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rac gtpase activating protein 1; gtpase activating protein. [source:refseq;acc:nm\_013277]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5521.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5856.93\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06083\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1942\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pre-mrna cleavage factor i, 59 kda subunit. [source:refseq;acc:nm\_024811]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5805.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6158.16\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1943\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
p300/cbp-associated factor (ec 2.3.1.-) (p/caf) (histone acetylase pcaf). [source:swissprot;acc:q92831]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7210.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7649.23\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06079\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1944\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
general control of amino acid synthesis protein 5-like 2 (ec 2.3.1.-) (histone acetyltransferase gcn5) (hsgcn5). [source:swissprot;acc:q92830]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7210.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7648.94\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1945\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cofilin, non-muscle isoform (18 kda phosphoprotein) (p18). [source:swissprot;acc:p23528]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6230.21\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6608.64\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06074\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1946\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cofilin, muscle isoform (cofilin 2). [source:swissprot;acc:q9y281]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1947\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription initiation factor tfiid 100 kda subunit (tafii-100) (tafii100). [source:swissprot;acc:q15542]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7195.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7632.83\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1948\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
destrin (actin-depolymerizing factor) (adf). [source:swissprot;acc:p18282]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6230.21\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6608.64\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1949\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin fusion degradation protein 1 homolog (ub fusion protein 1). [source:swissprot;acc:q92890]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/